At the news
? NEUTRALIMPACT 2/10 144 filed May 13, 2026 at 13:06 ET
Officer Alane P. Barnes filed a Form 144 indicating intent to sell 62,500 shares of BioCryst Pharmaceuticals (BCRX), valued at approximately $596,250. The shares are from an option grant dated 2017. Given the relatively small size relative to market cap ($2.2B) and no apparent negative catalyst, the filing is routine.
- Reporting person: Alane P. Barnes (Officer)
- Proposed sale: 62,500 shares of common stock
- Estimated value: $596,250 (based on filing date price)
- Shares acquired via option granted on 12/20/2017
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access